125 related articles for article (PubMed ID: 35342938)
1. Telomere maintenance mechanism dysregulation serves as an early predictor of adjuvant therapy response and a potential therapeutic target in human cancers.
Zhang Y; Luo S; Jia Y; Zhang X
Int J Cancer; 2022 Jul; 151(2):313-327. PubMed ID: 35342938
[TBL] [Abstract][Full Text] [Related]
2. Pan-Cancer Analysis of Clinical Relevance via Telomere Maintenance Mechanism.
Sung JY; Cheong JH
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681758
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer analysis of telomere maintenance mechanisms.
Hakobyan M; Binder H; Arakelyan A
J Biol Chem; 2024 May; 300(6):107392. PubMed ID: 38763334
[TBL] [Abstract][Full Text] [Related]
4. Telomere maintenance mechanisms in cancer: clinical implications.
Reddel RR
Curr Pharm Des; 2014; 20(41):6361-74. PubMed ID: 24975603
[TBL] [Abstract][Full Text] [Related]
5. Pan-Cancer Analysis of Alternative Lengthening of Telomere Activity.
Sung JY; Lim HW; Joung JG; Park WY
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32784588
[TBL] [Abstract][Full Text] [Related]
6. Telomere Length Maintenance and Its Transcriptional Regulation in Lynch Syndrome and Sporadic Colorectal Carcinoma.
Nersisyan L; Hopp L; Loeffler-Wirth H; Galle J; Loeffler M; Arakelyan A; Binder H
Front Oncol; 2019; 9():1172. PubMed ID: 31750255
[No Abstract] [Full Text] [Related]
7. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
De Vitis M; Berardinelli F; Sgura A
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
[TBL] [Abstract][Full Text] [Related]
8. Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.
Koneru B; Lopez G; Farooqi A; Conkrite KL; Nguyen TH; Macha SJ; Modi A; Rokita JL; Urias E; Hindle A; Davidson H; Mccoy K; Nance J; Yazdani V; Irwin MS; Yang S; Wheeler DA; Maris JM; Diskin SJ; Reynolds CP
Cancer Res; 2020 Jun; 80(12):2663-2675. PubMed ID: 32291317
[TBL] [Abstract][Full Text] [Related]
9. Single Cell Analysis of Gastric Cancer Reveals Non-Defined Telomere Maintenance Mechanism.
Sung JY; Cheong JH
Cells; 2022 Oct; 11(21):. PubMed ID: 36359738
[TBL] [Abstract][Full Text] [Related]
10. TCGA Pan-Cancer Genomic Analysis of Alternative Lengthening of Telomeres (ALT) Related Genes.
Armendáriz-Castillo I; López-Cortés A; García-Cárdenas J; Guevara-Ramírez P; Leone PE; Pérez-Villa A; Yumiceba V; Zambrano AK; Guerrero S; Paz-Y-Miño C
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32708340
[TBL] [Abstract][Full Text] [Related]
11. Human sarcomas are mosaic for telomerase-dependent and telomerase-independent telomere maintenance mechanisms: implications for telomere-based therapies.
Gocha AR; Nuovo G; Iwenofu OH; Groden J
Am J Pathol; 2013 Jan; 182(1):41-8. PubMed ID: 23260199
[TBL] [Abstract][Full Text] [Related]
12. Telomere maintenance mechanisms in cancer: telomerase, ALT or lack thereof.
Claude E; Decottignies A
Curr Opin Genet Dev; 2020 Feb; 60():1-8. PubMed ID: 32114293
[TBL] [Abstract][Full Text] [Related]
13. SLX4IP and telomere dynamics dictate breast cancer metastasis and therapeutic responsiveness.
Robinson NJ; Morrison-Smith CD; Gooding AJ; Schiemann BJ; Jackson MW; Taylor DJ; Schiemann WP
Life Sci Alliance; 2020 Apr; 3(4):. PubMed ID: 32071280
[TBL] [Abstract][Full Text] [Related]
14. Whole-genome profiling in liposarcomas reveals genetic alterations common to specific telomere maintenance mechanisms.
Johnson JE; Gettings EJ; Schwalm J; Pei J; Testa JR; Litwin S; von Mehren M; Broccoli D
Cancer Res; 2007 Oct; 67(19):9221-8. PubMed ID: 17909028
[TBL] [Abstract][Full Text] [Related]
15. Telomere Maintenance Pathway Activity Analysis Enables Tissue- and Gene-Level Inferences.
Nersisyan L; Simonyan A; Binder H; Arakelyan A
Front Genet; 2021; 12():662464. PubMed ID: 33897770
[TBL] [Abstract][Full Text] [Related]
16. The first molecular details of ALT in human tumor cells.
Muntoni A; Reddel RR
Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R191-6. PubMed ID: 16244317
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional landscape of DNA repair genes underpins a pan-cancer prognostic signature associated with cell cycle dysregulation and tumor hypoxia.
Chang WH; Lai AG
DNA Repair (Amst); 2019 Jun; 78():142-153. PubMed ID: 31054516
[TBL] [Abstract][Full Text] [Related]
18. Alternative Lengthening of Telomeres: DNA Repair Pathways Converge.
Sobinoff AP; Pickett HA
Trends Genet; 2017 Dec; 33(12):921-932. PubMed ID: 28969871
[TBL] [Abstract][Full Text] [Related]
19. Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.
Ulaner GA; Huang HY; Otero J; Zhao Z; Ben-Porat L; Satagopan JM; Gorlick R; Meyers P; Healey JH; Huvos AG; Hoffman AR; Ladanyi M
Cancer Res; 2003 Apr; 63(8):1759-63. PubMed ID: 12702558
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes.
Luo Z; Wang W; Li F; Songyang Z; Feng X; Xin C; Dai Z; Xiong Y
Mol Cancer; 2019 Jun; 18(1):106. PubMed ID: 31179925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]